NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Publishes Unprecedented Full Genome Dataset from MINDACT Trial for the Advancement of Translational Research in Communications Biology
PRESS RELEASE Irvine, California., July 27, 2020 โย Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the publication of MINDACT trial data in the July 27 issue of Communications Biology, a Read More
General Standby Statement
Agendia, Inc. has entered into a Settlement Agreement with the U.S. Department of Justice (DOJ) acting on behalf of the Office of Inspector General of the Department of Health and Human Services (OIG-HHS) to resolve Read More
Agendia Announces Data Presented at ASCO 2020 Demonstrating Importance of Further Classification of Breast Cancers to Enable Precise Prognosis and Treatment
PRESS RELEASE Presentations outline how BluePrintโยฎโ genomic testing enables further categorization of HER2-positive cancer and reclassification of ER+ tumors for patientsโ benefit FLEX registry reinforces the clinical and real-world utility of MammaPrintยฎ and BluePrint to Read More